DD250117P72000
- 0.15
- 0.000.00%
DuPont Newsroom
Gilbert Dupont Upgrades Sartorius Stedim Biotech to Buy, Boosts PT
Express News | Dupont : RBC Cuts Target Price to $101 From $104
Jim Cramer Talks DuPont De Nemours (DD) and Its AI Semiconductor Spin-Off Plans – Here's Why
Food Enzymes Market Research Report 2025-2033, Featuring Advanced Enzyme Technologies, Novozymes, DuPont Danisco, Kerry Group, Associated British Foods, Chr. Hansen Holding, EDC, and Dyadic International
Will DuPont De Nemours (DD) Beat Estimates Again in Its Next Earnings Report?
An 850-Acre Hunting Property in Maryland Lists for the First Time in Nearly a Century -- WSJ
Isobutanol Industry Research Report 2024-2030 Featuring 40+ Major Players Including BASF, Dow, DuPont De Nemours, Eastman Chemical Company, Gevo
D2 Capital Advisors Arranges $23,500,000 Construction Financing for Chestnut Run Innovation & Science Park Hotel in Wilmington, DE
An Auto Supplier Is Breaking Up. It's the Latest in a Hot Wall Street Trend.
Here's Why DuPont De Nemours (DD) Is a Strong Momentum Stock
Mauna Kea Technologies: Half-Year Liquidity Contract Statement for H2 2024 With the Brokerage Firm Gilbert Dupont
DuPont MOLYKOTE HP-300 Grease Proven to Meet Strict Hydrogen Purity Standards
Is There Now An Opportunity In DuPont De Nemours, Inc. (NYSE:DD)?
Wolfe Research Upgrades DuPont(DD.US) to Buy Rating, Announces Target Price $91
DuPont Offers Updates on Separation Plans and Reaffirms Guidance
A Quick Look at Today's Ratings for DuPont(DD.US), With a Forecast Between $91 to $116
Wolfe Upgrades DuPont De Nemours to Outperform From Peer Perform, Price Target Is $91
DuPont's Promising Growth Trajectory: Buy Rating Amidst Easing Macroeconomic Challenges and Strategic Management Changes
Analyst Expectations For DuPont De Nemours's Future
Here Is Where Cramer Stands on DuPont After Key Spin-off and Guidance Updates